Skip to main content

Personalised cancer treatments targeting chemokine receptors

Advertisement

CXCR4 is an important surface receptor found on immune and cancer cells. When this chemokine receptor is present in large numbers on cancer cells, one of the roles it plays is to enable them to migrate and form metastases. CXCR4 is also involved in every inflammatory process. The site of inflammation releases signalling molecules known as chemokines. In the lymph nodes, these cause immune cells to develop a large number of CXCR4 receptors, enabling the immune cells to locate the site of inflammation and migrate there.

In recent years, this molecular receptor has sparked a heated debate amongst experts because its ‘relationship status’ remained a mystery. Does it exist as a single molecule or as a pair? The answer has been provided by research carried out by the team led by Ali Isbilir at the Max Delbrück Centre for Molecular Medicine. It turns out the receptor prefers to keep its options open: it exists sometimes as a single unit (monomer) and sometimes as a pair (dimer).

This finding is important not only for basic research but also for the pharmaceutical industry. The researchers were able to show that certain drugs, which act as CXCR4 blockers, can suppress the formation of pairs. It is believed that CXCR4 pairs are harmful to health. Thanks to a newly developed fluorescence method, living cancer cells can now be examined directly, enabling CXCR4 blockers to be applied to both paired and single molecules and tested to determine which are more effective against tumours. This could, for example, lead to the development of more specific cancer drugs with fewer side effects, and enable cancer treatments to be tailored to the individual and made as effective as possible.

Reference:
MDC Berlin; Helmholtz Association

Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerisation by subpocket-specific inverse agonists, PNAS 2021, https://www.pnas.org/content/117/46/29144
Determination of G-protein-coupled receptor oligomerisation by molecular brightness analyses in single cells; Nature Protocols 2021, https://www.nature.com/articles/s41596-020-00458-1

  • Author

    Gernot Hofer

More on this topic
Hormones

Low testosterone in men: symptoms, causes and treatment

Fatigue, a reduced sex drive, and a lack of energy: these symptoms can have many causes. One possible explanation is a testosterone deficiency. However, it is not possible to determine whether testosterone levels are actually too low based solely on the symptoms or on a single blood test result.

Men's health
Men's health

PSA level: What does it mean, and when is it too high?




The PSA level is one of the best-known laboratory test results relating to the prostate. Many men come across it for the first time during a screening examination or when having symptoms investigated. An abnormal result often raises questions: Is this already a sign of prostate cancer? What levels are considered normal?

Prostate
Pollen allergy

The right diet for hay fever

Anyone suffering from hay fever should pay particular attention to their diet so as not to make the symptoms any worse.

Nutrition
Urology

Prostate health: What men need to know

The prostate is a gland in a man’s body that is only the size of a chestnut, but it plays a crucial role in well-being, urinary function and male sexuality. Benign enlargement and prostate cancer become more common in older age.

Prostate